Picture of Teleflex logo

TFX Teleflex Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Teleflex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue2,5952,5372,8102,7912,974
Cost of Revenue
Gross Profit1,4921,3251,5501,5311,647
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses2,1772,1142,1942,2922,468
Operating Profit418423615499506
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes340358559446434
Provision for Income Taxes
Net Income After Taxes462336485363358
Net Income Before Extraordinary Items
Extraordinary Items
Net Income461335485363356
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income461335485363356
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS10.28.599.27.928.54
Dividends per Share